Meridian Bioscience is a life science company with principal businesses in the development, manufacture, sale and distribution of diagnostic testing systems and kits and the manufacture and distribution of bulk antigens, antibodies, immunoassay blocking reagents, Polymerase Chain Reaction (PCR) master mixes and bioresearch reagents. Co.'s reportable segments are: Diagnostics, which includes diagnostic tests and transport media; and Life Science, which develops, manufactures, sells and distributes bulk antigens, antibodies, immunoassay blocking reagents, PCR master mixes, isothermal reagents, enzymes, nucleotides and bioresearch reagents.
|
Free VIVO Email Alerts: Get SEC Filing Alerts Get Dividend Alerts |
Hold (2.00 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Analysts' Target Price: VIVO Stock Forecast Based on Zacks ABR data; powered by Xignite |